Who owns MNPR?
Institutional ownership of Monopar Therapeutics Inc. from Form 13F, Q2 2026
96 institutional managers reported holding Monopar Therapeutics Inc. (MNPR) in Form 13F filings for Q2 2026, with 6,222,201 shares worth $576M. The largest reported holder was Jupiter Topco LLC. Managers that filed both quarters cut a net 7,920 shares (-0.2%). 29 opened new positions and 14 sold out.
- Funds holding
- 96
- Value held
- $576M
- New / sold out
- 29 / 14
- Net shares, same filers
- -0.2%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of MNPR
Share of 13F holdings is each fund's shares as a share of the 6,222,201 MNPR shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Orbimed Advisors LLC New+$14.6M
- Candriam S.C.A. New+$13.3M
- TCG Crossover Management, LLC Added+$6.6M
- Longaeva Partners L.P. New+$5.2M
- Driehaus Capital Management LLC Added+$4.7M
- Ikarian Capital, LLC New+$4.4M
- BlackRock, Inc. Added+$3.0M
- Stempoint Capital LP New+$2.8M
- Boothbay Fund Management, LLC New+$1.4M
- Neuberger Berman Group LLC Added+$1.2M
Biggest sellers in Q2 2026
- Sio Capital Management, LLC Sold out-$9.5M
- Adage Capital Partners GP, L.l.c. Trimmed-$9.3M
- Bank of America Corp Trimmed-$5.2M
- ADAR1 Capital Management, LLC Trimmed-$4.3M
- Price T Rowe Associates Inc Trimmed-$4.1M
- Walleye Capital LLC Sold out-$3.5M
- Saturn V Capital Management LP Trimmed-$3.1M
- Silverarc Capital Management, LLC Sold out-$2.4M
- Citadel Advisors LLC Trimmed-$2.0M
- Barclays PLC Trimmed-$1.8M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $70.0M and sold $57.3M; 32 added and 24 trimmed.
Schedule 13D and 13G filings on MNPR
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-10-27BlackRock, Inc. SCHEDULE 13G filed by BlackRock Inc.Schedule 13G
- 2025-02-12Adage Capital Management, L.P. SCHEDULE 13G filed by Monopar Therapeutics Inc.Schedule 13G
Questions about MNPR ownership
- Who owns MNPR stock?
- 96 institutional investment managers reported MNPR positions in their Form 13F filings for Q2 2026, holding 6,222,201 shares worth $576M in total. Jupiter Topco LLC reported the largest position.
- Are funds buying or selling MNPR?
- In Q2 2026, 29 managers opened new MNPR positions, 32 added, 24 trimmed and 14 sold out. Managers that filed in both quarters sold a net 7,920 shares.
- How current is this MNPR institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to MNPR by CUSIP. Options are left out. MNPR news and filings · MNPR insider trades · Top funds